Guangzhou Baiyunshan Pharmaceutical Holdings has received the Drug Registration Certificate for Vero cell human rabies vaccine (freeze-dried) from Guangzhou Baiyunshan Pharmaceutical Holdings Biologics.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that recently, its subsidiary Guangzhou Baiyunshan Pharmaceutical Holdings Biological Products Co., Ltd. ("Guangzhou Baiyunshan Pharmaceutical Holdings Biological") has received the approval and issuance of the "Drug Registration Certificate" for Freeze-Dried Human Rabies Vaccine (Vero Cell) from the National Medical Products Administration. The Freeze-Dried Human Rabies Vaccine (Vero Cell) is used for the prevention of rabies. By obtaining the "Drug Registration Certificate" for this vaccine, it will further enrich the company's product structure and enhance its competitiveness in the vaccine market. Guangzhou Baiyunshan Pharmaceutical Holdings Biological will actively carry out the production of Freeze-Dried Human Rabies Vaccine (Vero Cell) in accordance with the relevant requirements. Once the product obtains the Biological Product Batch Release Certificate from the National Medical Products Administration, it can be launched on the market for sale.